International Conference for the Society for Integrative Oncology

综合肿瘤学会国际会议

基本信息

项目摘要

DESCRIPTION (provided by applicant): Through its annual conferences, the Society for Integrative Oncology (SIO) provides a significant forum for presentation of current research and ground-breaking clinical applications of Complementary and Alternative Medicine (CAM) therapies in cancer care. Moreover, these conferences provide an atmosphere conducive to the exchange of important information, while promoting a deeper appreciation of how CAM can combine with conventional approaches in medicine to achieve optimal therapeutic outcomes for cancer patients. These objectives work in accordance with the mission of the NIH, as a mechanism of "science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability." These critical, high-level scientific conferences have been held annually since 2005, providing meaningful, current data on the integration of CAM modalities in the conventional care of cancer patients. This year, the venue is again New York -home to an expansive, forward thinking medical population that includes researchers and clinicians from some of the most prestigious traditional and complementary medicine training and research programs in the country. The large number of local CAM professionals is thus leveraged not only as a potential audience, but as members of the Faculty. The non-profit Society for Integrative Oncology (SIO) was established to be the prime driving force for the reasoned application of evidence-based CAM therapies into conventional cancer care. The SIO is the main sponsor of this conference; the Scientific Program Committee includes senior professionals from major cancer centers throughout the United States and member countries. We anticipate over 300 attendees, primarily active CAM and conventional practitioners involved in cancer patient care. A large minority of oncologists is expected to take part. The specific aims of this application are to establish an annual evidence-based meeting to: 1) introduce recent clinical and basic science evidence regarding Integrative therapies in cancer care to new and established investigators; 2) promote collaboration between national and international centers of excellence in Integrative Oncology to enhance availability of high quality research in complementary and alternative methods of symptom management; 3) provide continuing education and a forum for exchange of future research ideas between experienced investigators and integrative practitioners. PUBLIC HEALTH RELEVANCE: Complementary and Alternative medical (CAM) therapies are used by a large majority of cancer patients, usually without sufficient research into their mechanisms of action, efficacy, or toxicity. The Society for Integrative Oncology (SIO) is devoted to the prudent research and clinical application of CAM therapies in cancer. The annual SIO International Conference, and the Society's journal, serve as vehicles to review and discuss research and clinical outcomes of CAM use in the oncology milieu.
描述(由申请人提供):通过其年度会议,综合肿瘤学会 (SIO) 提供了一个重要的论坛,用于展示补充和替代医学 (CAM) 疗法在癌症护理中的当前研究和突破性临床应用。此外,这些会议提供了有利于交流重要信息的氛围,同时促进人们更深入地了解 CAM 如何与传统医学方法相结合,为癌症患者实现最佳治疗结果。这些目标与 NIH 的使命相一致,即“科学追求有关生命系统的性质和行为的基础知识,并应用这些知识来延长健康寿命并减少疾病和残疾的负担”。 ” 这些重要的高级别科学会议自 2005 年以来每年举行一次,提供有关 CAM 模式整合到癌症患者常规护理中的有意义的最新数据。今年的举办地再次是纽约,这里聚集了众多具有前瞻性的医学人群,其中包括来自美国一些最负盛名的传统和补充医学培训和研究项目的研究人员和临床医生。因此,大量的本地 CAM 专业人士不仅可以作为潜在的受众,而且可以作为学院的成员。非营利性综合肿瘤学会 (SIO) 的成立是为了将循证 CAM 疗法合理应用到传统癌症治疗中的主要推动力。 SIO是本次会议的主要赞助单位;科学计划委员会包括来自美国和成员国主要癌症中心的高级专业人员。 我们预计将有超过 300 名与会者,其中主要是活跃的 CAM 和参与癌症患者护理的传统从业者。预计大部分肿瘤学家将参加。 本申请的具体目标是建立年度循证会议,以便: 1) 向新的和已建立的研究者介绍有关癌症治疗中综合疗法的最新临床和基础科学证据; 2) 促进国家和国际综合肿瘤学卓越中心之间的合作,以提高症状管理补充和替代方法方面高质量研究的可用性; 3)提供继续教育和论坛,以便经验丰富的研究者和综合实践者之间交流未来的研究想法。 公共健康相关性:大多数癌症患者都使用补充和替代医学 (CAM) 疗法,但通常没有对其作用机制、功效或毒性进行充分的研究。综合肿瘤学会 (SIO) 致力于 CAM 疗法在癌症中的审慎研究和临床应用。年度 SIO 国际会议和学会期刊是回顾和讨论 CAM 在肿瘤学环境中使用的研究和临床结果的工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter A S Johnstone其他文献

Thirty-day mortality as a metric for palliative radiotherapy in pediatric patients
三十天死亡率作为儿科患者姑息性放射治疗的指标
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations
跨国癌症支持护理协会 (MASCC) 预防乳腺癌相关手臂淋巴水肿 (BCRAL) 的临床实践指南:基于国际德尔菲共识的建议
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
    Henry Wong;M. Wallen;Adrian Wai Chan;Narayanee Dick;Pierluigi Bonomo;Monique Bareham;J. R. Wolf;C. V. D. van den Hurk;M. Fitch;Edward L. Chow;Raymond J. Chan;Muna Belen Alonso Suvam Kira Pierluigi Pinar Yolande Do AlKhaifi Alvarez Banerjee Bloomquist Bonomo Borman;Muna AlKhaifi;Belen Alonso Alvarez;Suvam Banerjee;K. Bloomquist;Pierluigi Bonomo;Pinar Borman;Yolande Borthwick;Dominic Chan;Sze Man Chan;Y. Chan;Ngan Sum Jean Cheng;J. I. Choi;Edward L. Chow;Yin;Kimberly Corbin;Elizabeth Dylke;Pamela Hammond;Satoshi Hirakawa;Kimiko Hirata;Shing;Marianne Holt;Peter A S Johnstone;Y. Kikawa;Deborah Kirk;H. Kotani;C. Kwok;Jessica Lai;Mei Ying Lim;Michael Lock;Brittany Lorden;Page Mack;Stefano Magno;I. Meattini;Gustavo Nader Marta;Margaret McNeely;Tammy Mondry;Luis Enrique Lopez Montoya;Mami Ogita;Misato Osaka;Stephanie Phan;P. Poortmans;B. S. Rafn;A. Recht;A. Rembielak;A. Río;J. Robijns;Naoko Sanuki;Charles B. Simone;M. Spałek;K. Tane;L. F. Nevola Teixeira;M. Terada;Mark Trombetta;Kam Hung Wong;K. Yoshidome
  • 通讯作者:
    K. Yoshidome
Stereotactic Body Radiation Therapy versus Conventional External Beam Radiotherapy for Spinal Metastases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
立体定向全身放射治疗与传统外照射治疗脊柱转移瘤:随机对照试验的系统回顾和荟萃分析。
  • DOI:
    10.1016/j.radonc.2023.109914
  • 发表时间:
    2023-09-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Henry C Y Wong;Shing Fung Lee;Adrian Wai Chan;S. Caini;Peter Hoskin;C. B. Simone II;Peter A S Johnstone;Yvette M. van der Linden;J. M. van der Velden;Emily J Martin;S. Alcorn;Candice Johnstone;J. Isabelle Choi;Gustavo Nader Marta;E. Oldenburger;S. Raman;A. Rembielak;V. Vassiliou;Pierluigi Bonomo;Q. Nguyen;Edward L. Chow;S. Ryu
  • 通讯作者:
    S. Ryu

Peter A S Johnstone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter A S Johnstone', 18)}}的其他基金

International Conferences of the Society for Integrative Oncology
综合肿瘤学会国际会议
  • 批准号:
    7225167
  • 财政年份:
    2006
  • 资助金额:
    $ 1.2万
  • 项目类别:
International Conferences of the Society for Integrative Oncology
综合肿瘤学会国际会议
  • 批准号:
    7631666
  • 财政年份:
    2006
  • 资助金额:
    $ 1.2万
  • 项目类别:
International Conferences of the Society for Integrative Oncology
综合肿瘤学会国际会议
  • 批准号:
    7288364
  • 财政年份:
    2006
  • 资助金额:
    $ 1.2万
  • 项目类别:

相似国自然基金

碳基电磁屏蔽复合材料的双层结构设计及其吸收行为研究
  • 批准号:
    52302364
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于全文本引文解构的引用失范行为识别与生成机理研究
  • 批准号:
    72304181
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于行为因果推理的跨网络用户对齐技术研究
  • 批准号:
    62302303
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中熵合金低温协同强化及其多场耦合环境下应力腐蚀行为的研究
  • 批准号:
    52371070
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
面向真实场景的基于人体关节点的行为理解研究
  • 批准号:
    62302093
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
  • 批准号:
    10544369
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Role of PPARg in theFormation and Progression of Carcinoma in situ of the Bladder
BCCMA:暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:PPARg 在膀胱原位癌形成和进展中的作用
  • 批准号:
    10361590
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
(1/2) 庞塞健康科学大学-莫菲特癌症中心合作伙伴关系
  • 批准号:
    10658230
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
Center for Advanced Multi-Omic Characterization of Cancer
癌症高级多组学表征中心
  • 批准号:
    10439370
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
Center for Advanced Multi-Omic Characterization of Cancer
癌症高级多组学表征中心
  • 批准号:
    10631927
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了